Cytokinetics Inc

NASDAQ:CYTK   3:59:53 PM EDT
32.43
-0.57 (-1.73%)
Products

Cytokinetics Announces Receipt Of Breakthrough Therapy Designation From FDA For Aficamten

Published: 12/09/2021 14:25 GMT
Cytokinetics Inc (CYTK) - Cytokinetics Announces Receipt of Breakthrough Therapy Designation From FDA for Aficamten.